raltegravir-based antiretroviral therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for raltegravir-based antiretroviral therapy, covering 2023-10-19 to 2023-10-19. Get the full timeline:
Most recent: Clinical Trial Update: Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients [Phase 4]